Home/Filings/4/0001193125-25-338326
4//SEC Filing

Umberger Traci S 4

Accession 0001193125-25-338326

CIK 0001877184other

Filed

Dec 30, 7:00 PM ET

Accepted

Dec 31, 4:16 PM ET

Size

5.4 KB

Accession

0001193125-25-338326

Insider Transaction Report

Form 4
Period: 2025-12-29
Umberger Traci S
DirectorSee Remarks
Transactions
  • Sale

    Common Shares

    2025-12-29$26.69/sh10,500$280,201136,633 total
Footnotes (3)
  • [F1]The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2025.
  • [F2]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.51 to $26.96. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
  • [F3]Includes 12,797 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.

Documents

1 file

Issuer

KESTRA MEDICAL TECHNOLOGIES, LTD.

CIK 0001877184

Entity typeother

Related Parties

1
  • filerCIK 0001877198

Filing Metadata

Form type
4
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:16 PM ET
Size
5.4 KB